Preclinical News and Research

RSS
Argonne's Advanced Photon Source guided the development of new COVID-19 vaccine now in trials

Argonne's Advanced Photon Source guided the development of new COVID-19 vaccine now in trials

Animal study shows how chemical compound in Indian Long Pepper works against glioblastoma

Animal study shows how chemical compound in Indian Long Pepper works against glioblastoma

Study identifies how SARS-CoV-2 enters and infects the brain

Study identifies how SARS-CoV-2 enters and infects the brain

Chaperone protein imbalance can play key role in initiating toxic tau buildup in the aging brain

Chaperone protein imbalance can play key role in initiating toxic tau buildup in the aging brain

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

New nanomedicine device is effective for treating glioblastoma multiforme

New nanomedicine device is effective for treating glioblastoma multiforme

Scientists identify protein that operates closely with a genetic mutation to spur lung cancer growth

Scientists identify protein that operates closely with a genetic mutation to spur lung cancer growth

Study uncovers role for STING in regulating tumor response to DNA-damaging treatments

Study uncovers role for STING in regulating tumor response to DNA-damaging treatments

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Global scarcity of novel antibiotics drives the emergence and spread of antimicrobial resistance

Global scarcity of novel antibiotics drives the emergence and spread of antimicrobial resistance

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

Novel PET tracer is safe and can clearly identify early stages of rheumatoid arthritis

Novel PET tracer is safe and can clearly identify early stages of rheumatoid arthritis

Novel PET radiopharmaceutical shows promising results in first-in-humans study

Novel PET radiopharmaceutical shows promising results in first-in-humans study

Combination of 2-Photon 3D-printer and bioink allows precise, direct printing of living cells

Combination of 2-Photon 3D-printer and bioink allows precise, direct printing of living cells

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

New recipients for the 2021 NCCN Foundation Young Investigator Awards announced

New recipients for the 2021 NCCN Foundation Young Investigator Awards announced

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

Series of reviews discuss key issues in chronic kidney disease and bone disorders

Series of reviews discuss key issues in chronic kidney disease and bone disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.